1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one

C37H42F3N7O2 — CID 155244521

IUPAC1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one
SMILESC=CC(=O)N1CC2(CCN(c3nc(C4CN(C5CCC5)C4)nc4c(OCC(F)(F)F)c(-c5c(C)ccc6[nH]ncc56)c(CC)cc34)CC2)C1
InChIInChI=1S/C37H42F3N7O2/c1-4-23-15-26-32(33(49-21-37(38,39)40)31(23)30-22(3)9-10-28-27(30)16-41-44-28)42-34(24-17-46(18-24)25-7-6-8-25)43-35(26)45-13-11-36(12-14-45)19-47(20-36)29(48)5-2/h5,9-10,15-16,24-25H,2,4,6-8,11-14,17-21H2,1,3H3,(H,41,44)
InChIKeyAGNHAXKNZJCBEI-UHFFFAOYSA-N
MW673.78 g/mol
LogP6.55
Rot. Bonds8

About 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one

1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one (PubChem CID 155244521) has the molecular formula C37H42F3N7O2 and a molecular weight of 673.78 g/mol. Its IUPAC name is 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one.

Molecular Properties

Compound Name1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one
PubChem CID155244521
Molecular FormulaC37H42F3N7O2
Molecular Weight673.78 g/mol
Exact Mass673.34
IUPAC Name1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one
SMILESC=CC(=O)N1CC2(CCN(c3nc(C4CN(C5CCC5)C4)nc4c(OCC(F)(F)F)c(-c5c(C)ccc6[nH]ncc56)c(CC)cc34)CC2)C1
InChIInChI=1S/C37H42F3N7O2/c1-4-23-15-26-32(33(49-21-37(38,39)40)31(23)30-22(3)9-10-28-27(30)16-41-44-28)42-34(24-17-46(18-24)25-7-6-8-25)43-35(26)45-13-11-36(12-14-45)19-47(20-36)29(48)5-2/h5,9-10,15-16,24-25H,2,4,6-8,11-14,17-21H2,1,3H3,(H,41,44)
InChIKeyAGNHAXKNZJCBEI-UHFFFAOYSA-N
XLogP6.55
TPSA90.48 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms49
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500673.78
LogP ≤ 56.55
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one?
The IUPAC name of 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one (CID 155244521) is 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one.
What is the SMILES notation for 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one?
The canonical SMILES for 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one is C=CC(=O)N1CC2(CCN(c3nc(C4CN(C5CCC5)C4)nc4c(OCC(F)(F)F)c(-c5c(C)ccc6[nH]ncc56)c(CC)cc34)CC2)C1.
What is the InChIKey of 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one?
The InChIKey is AGNHAXKNZJCBEI-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H42F3N7O2/c1-4-23-15-26-32(33(49-21-37(38,39)40)31(23)30-22(3)9-10-28-27(30)16-41-44-28)42-34(24-17-46(18-24)25-7-6-8-25)43-35(26)45-13-11-36(12-14-45)19-47(20-36)29(48)5-2/h5,9-10,15-16,24-25H,2,4,6-8,11-14,17-21H2,1,3H3,(H,41,44).
What are the key properties of 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one?
1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one has a molecular weight of 673.78 g/mol, XLogP of 6.55, 8 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[7-[2-(1-cyclobutylazetidin-3-yl)-6-ethyl-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)quinazolin-4-yl]-2,7-diazaspiro[3.5]nonan-2-yl]prop-2-en-1-one is sourced from PubChem (CID 155244521), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).